Welcome to the new Gustave Roussy website

A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.

Press releases

When meals make the daily lives of patients easier

On

April 2017

When meals make the daily lives of patients easier

The hospital environment combines excellence of care, rigorous hygiene and diversity in terms of the length of patient stays and variety of pathologies. In this environment, there has been a global raising of awareness to the role catering has to play in patient recovery and the fact that meal and snack times are sources of well-being for patients and their visitors.

This is something which Gustave Roussy, Elior and Alexandre Bourdasholds very dear. As such, they joined forces to create a customized catering solution for cancer patients that puts pleasure at the heart of the eating experience. Gustave Roussy, premier European Cancer Center, called on Elior, leader in contract catering in France, to lend its catering expertise and meet the needs and expectations of the hospital’s patients. It became apparent that SaQuaNa** chef, Alexandre Bourdas was the obvious choice to join the team. Renowned for his simple and tasty cuisine, the Chef has created a collection of recipes specially designed to help patients rediscover the pleasure of eating.

The encounter of these players coming from three different worlds enabled the creation of a tasty catering offering adapted to meet the needs of cancer patients. Menus designed to take account of the side effects of treatments such as chemotherapy are proposed to all adult patients.

Press contact

If you are a journalist and have a question, please contact:

Claire Parisel or Léona Pinto
Tel. +33 1 42 11 50 59
Tel. +33 1 42 11 63 59
Mob. +33 6 17 66 00 26
Email

The Media Team cannot respond to patient inquiries.

Last press releases

  • Gold september: two new research programmes launched to tackle childhood cancers

    Two of Gustave Roussy’s four new medical and scientific programmes are dedicated to childhood cancers. The first, DECRIPT, aims to improve understanding of the role played by genetics in the development of certain childhood cancers, as well as second cancers that may occur in adulthood. The second, INSPIRE, will draw on the knowledge and techniques already developed at the Institute to create organoids, with the aim of deciphering the mechanisms underlying metastasis and resistance to treatment.

    Photographie enfant pédiatrie
  • Prof. Fabrice Barlesi reappointed at the head of Gustave Roussy, the leading cancer center in France and Europe

    By order of Ms. Stéphanie Rist, Minister of Health, Families, Autonomy and Persons with Disabilities, dated 27 July 2026, Professor Fabrice Barlesi has been reappointed as Director General of Gustave Roussy, effective 1 August 2026. At the helm of the Institute for five more years, Prof. Barlesi will continue the transformations undertaken during his first term. This renewal reflects the confidence placed in the project led by the institution to accelerate progress in the fight against cancer, foster and support the development of innovations set to change the future of oncology, and strengthen the influence of one of the world's leading cancer centers.

    Fabrice Barlesi
  • Route du Rhum 2026 Jean Le Cam and Christophe Rateau to sail for Gustave Roussy

    For the Route du Rhum - Destination Guadeloupe 2026, Jean Le Cam and Christophe Rateau will sail under the colors of Gustave Roussy, the leading cancer center in France and Europe. Competing respectively in the Vintage and Class40 categories, the two skippers will carry the Institute's mission to the general public, supporting cancer research and raising awareness of prevention, innovation and patient care.

    Jean Le Cam - Christophe Rateau
  • Owkin and Gustave Roussy partner to bring K Pro into real-world clinical practice

    Owkin and Gustave Roussy, Europe's leading cancer center, today announced a partnership to test K Pro directly within the hospital's real-world clinical and research workflows.